Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-068373

Chief Accounting Officer sold 5,000 shares at $26.00 ($130,000)

  • Chief Accounting Officer acquired 5,000 shares (option exercise)
  • Chief Accounting Officer acquired 920 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas Chief Accounting Officer 2023-12-01 Option exercise 10b5-1 +2,568 $11.35 $29,147 8,422 D
Lyon Joseph Douglas Chief Accounting Officer 2023-12-01 Sale 10b5-1 −2,568 $26.00 $66,768 5,854 D
Lyon Joseph Douglas Chief Accounting Officer 2023-12-04 Option exercise 10b5-1 +2,432 $11.35 $27,603 8,286 D
Lyon Joseph Douglas Chief Accounting Officer 2023-12-04 Sale 10b5-1 −2,432 $26.00 $63,232 5,854 D
Lyon Joseph Douglas Chief Accounting Officer 2023-12-01 Grant or award 10b5-1 +460 $25.97 $11,946 6,314 D
Lyon Joseph Douglas Chief Accounting Officer 2023-12-01 Grant or award 10b5-1 +460 6,774 D
Derivatives
Lyon Joseph Douglas Chief Accounting Officer 2023-12-01 Option exercise · Stock option (right to buy) 10b5-1 −5,000 44,167 D
Open-market sales · 5,000 sh · avg $26.00 · $130,000
Loading xslF345X05/ownership.xml…